170
Participants
Start Date
March 26, 2014
Primary Completion Date
June 20, 2017
Study Completion Date
June 20, 2017
Valacyclovir HCI 500 mg tablets
Valacyclovir HCI 500 mg capsules 6/day oral for 16 weeks
placebo
placebo capsules 6/day oral for 16 weeks
Centers for Behavioral Health, LLC, Rockville
Sheppard Pratt Health System, Towson
Maryland Psychiatric Research Center, Baltimore
Innovative Clinical Research, Inc., Lauderhill
Prevention and Recovery Center for Early Psychosis, Indianapolis
Indiana University Psychotic Disorders Clinic, Indianapolis
University of Kansas Medical Center-Witchita, Wichita
Laureate Institute for Brain Research, Tulsa
University of California, Los Angeles, Los Angeles
C.I. Trials, Inc.-Los Angeles County, Bellflower
University of California, Riverside at C.I. Trials, Inc.-Inland Empire, Riverside
C.I. Trials, Inc.-Orange County, Santa Ana
Yale University, New Haven
Stanley Medical Research Institute
OTHER
Sheppard Pratt Health System
OTHER
University of Maryland
OTHER
Centers for Behavioral Health, LLC
UNKNOWN
Laureate Institute for Brain Research, Inc.
OTHER
University of Kansas Medical Center
OTHER
University of California, Los Angeles
OTHER
Yale University
OTHER
Innovative Clinical Research, Inc.
INDUSTRY
University of California Riverside at C.I. Trials, Inc.-Inland Empire
UNKNOWN
Clinical Innovations
INDUSTRY
Indiana University
OTHER